Health and Healthcare

Jazz Pharmaceuticals : JAZZ

All Jazz Pharmaceuticals Articles

81 Articles

Chris Lange | Dec 8, 2018 at 7:20 AM EST

Major Health Care Catalysts Coming by the End of 2018

24/7 Wall St. takes a look at what is coming up in the FDA calendar regarding biotech and pharmaceutical companies…

Jon C. Ogg | Aug 8, 2018 at 9:10 AM EDT

Top Analyst Upgrades and Downgrades: AECOM, CyberArk, Dillard’s, Hasbro, Mattel, Newell, Papa John’s, Shopify, Snap, Tesla and More

The top analyst upgrades, downgrades and other research calls from Wednesday include AECOM, CyberArk, Dillard's, Hasbro, Mattel, Newell, Papa John's,…

Jon C. Ogg | Jul 11, 2018 at 9:05 AM EDT

Top Analyst Upgrades and Downgrades: AT&T, Comcast, Disney, Hess, Netflix, Petrobras, Sirius XM, Texas Instruments, Verizon and More

The top analyst upgrades, downgrades and other research calls from Wednesday include AT&T, Comcast, Hess, Netflix, Petrobras, Sirius XM, Texas…

Lee Jackson | May 10, 2018 at 10:05 AM EDT

4 Specialty Pharma Stocks That Deutsche Bank Likes for the Rest of 2018

There is deep value for long-term investors in these specialty pharmaceutical companies, and the ability to buy in to some…

Lee Jackson | Mar 19, 2018 at 9:00 AM EDT

Top Analyst Upgrades and Downgrades: AstraZeneca, Dr Pepper Snapple, Fortinet, GrubHub, Jazz Pharmaceutical, Unilever and More

Monday’s top analyst upgrades, downgrades and initiations include AstraZeneca, Dr Pepper Snapple, Fortinet, GrubHub, Jazz Pharmaceutical and Unilever.

Lee Jackson | Jan 4, 2018 at 10:45 AM EST

Stifel Has 5 Specialty Pharmaceutical 2018 Buys With Massive Upside Potential

24/7 Wall St. screened the Stifel specialty pharmaceutical list and found five stock rated Buy that have massive upside potential…

Lee Jackson | Dec 31, 2017 at 10:15 AM EST

Analysts Have 12 Top Biotech Picks for Big Upside in 2018

There can be some big biotech winners in 2018, given the changing landscape, and any of these 12 could be…

Lee Jackson | Nov 30, 2017 at 10:00 AM EST

Merrill Lynch Bullish on Deep Value Pharmaceuticals: 5 Stocks to Buy for 2018

One area to look at in this overbought and pricey market is pharmaceuticals. These five now are considered to be…

Trey Thoelcke | Aug 30, 2017 at 1:05 PM EDT

ImmunoGen Riding High on Jazz Pharma Deal

ImmunoGen announced this week that it has decided to partner with Jazz Pharmaceuticals, and investors have pushed Immunogen shares to…

Chris Lange | Aug 29, 2017 at 10:10 AM EDT

ImmunoGen and Jazz Enter Into Global Collaboration

ImmunoGen has decided to partner with Jazz Pharmaceuticals for the development and commercialization of two early-stage, hematology-related antibody-drug conjugate programs.

Jon C. Ogg | May 15, 2017 at 9:15 AM EDT

Top Analyst Upgrades and Downgrades: Applied Materials, Cerner, Cisco, J&J, Level 3, Salesforce and Many More

The top analyst upgrades, downgrades and other research calls from Monday include Applied Materials, Cerner, Cisco Systems, Johnson & Johnson,…

Jon C. Ogg | Apr 6, 2017 at 8:55 AM EDT

Top Analyst Upgrades and Downgrades: AMD, Panera, SeaWorld, T-Mobile, Walgreens, 8Point3 and Many More

The top analyst upgrades, downgrades and initiations seen on Thursday include AMD, Panera, SeaWorld, T-Mobile, Walgreens and 8Point3.

Chris Lange | Jan 18, 2017 at 11:05 AM EST

Wednesday’s Top Biopharma Winners

Trump said last week that companies in the health care sector are “getting away with murder,” and that something had…

Lee Jackson | Aug 12, 2016 at 8:25 AM EDT

Why This Analyst Sees Huge Upside for Valeant and 2 More Specialty Pharmas

All three of these specialty pharmaceutical stocks come with a fair share of risk but provide big upside potential as…

Paul Ausick | May 31, 2016 at 8:35 AM EDT

Jazz Pharma Pays $1.5 Billion for Celator

Jazz Pharmaceuticals announced Tuesday morning that it has reached a definitive agreement to acquire Celator Pharmaceuticals for about $1.5 billion.

1 2 3 4 5 6

Jazz Pharmaceuticals : JAZZ

All Jazz Pharmaceuticals Articles

Major Health Care Catalysts Coming by the End of 2018

Top Analyst Upgrades and Downgrades: AECOM, CyberArk, Dillard’s, Hasbro, Mattel, Newell, Papa John’s, Shopify, Snap, Tesla and More

Top Analyst Upgrades and Downgrades: AT&T, Comcast, Disney, Hess, Netflix, Petrobras, Sirius XM, Texas Instruments, Verizon and More

4 Specialty Pharma Stocks That Deutsche Bank Likes for the Rest of 2018

Top Analyst Upgrades and Downgrades: AstraZeneca, Dr Pepper Snapple, Fortinet, GrubHub, Jazz Pharmaceutical, Unilever and More

Stifel Has 5 Specialty Pharmaceutical 2018 Buys With Massive Upside Potential

Analysts Have 12 Top Biotech Picks for Big Upside in 2018

Merrill Lynch Bullish on Deep Value Pharmaceuticals: 5 Stocks to Buy for 2018

ImmunoGen Riding High on Jazz Pharma Deal

ImmunoGen and Jazz Enter Into Global Collaboration

Top Analyst Upgrades and Downgrades: Applied Materials, Cerner, Cisco, J&J, Level 3, Salesforce and Many More

Top Analyst Upgrades and Downgrades: AMD, Panera, SeaWorld, T-Mobile, Walgreens, 8Point3 and Many More

Wednesday’s Top Biopharma Winners

Why This Analyst Sees Huge Upside for Valeant and 2 More Specialty Pharmas

Jazz Pharma Pays $1.5 Billion for Celator

Jim Cramer to Brinker’s CEO: How Do You Make More Money When Every Cost Is Going the Wrong Way?

Retirees Are Realizing a $1.5 Million Nest Egg at 60 Only Means $31,000 in Real Annual Spending

Turning $250K Into $1M in 5 Years: Why This Real Estate Promise Is a Red Flag

Retirees Are Realizing a $1.5 Million Nest Egg at 60 Only Means $31,000 in Real Annual Spending

71% of Americans With Financial Advisors Feel Secure. Only 10% Without One Do

Jim Cramer to Brinker’s CEO: How Do You Make More Money When Every Cost Is Going the Wrong Way?

Retirees Are Realizing a $1.5 Million Nest Egg at 60 Only Means $31,000 in Real Annual Spending

Jazz Pharmaceuticals : JAZZ

All Jazz Pharmaceuticals Articles

Major Health Care Catalysts Coming by the End of 2018

Top Analyst Upgrades and Downgrades: AECOM, CyberArk, Dillard’s, Hasbro, Mattel, Newell, Papa John’s, Shopify, Snap, Tesla and More

Top Analyst Upgrades and Downgrades: AT&T, Comcast, Disney, Hess, Netflix, Petrobras, Sirius XM, Texas Instruments, Verizon and More

4 Specialty Pharma Stocks That Deutsche Bank Likes for the Rest of 2018

Top Analyst Upgrades and Downgrades: AstraZeneca, Dr Pepper Snapple, Fortinet, GrubHub, Jazz Pharmaceutical, Unilever and More

Stifel Has 5 Specialty Pharmaceutical 2018 Buys With Massive Upside Potential

Analysts Have 12 Top Biotech Picks for Big Upside in 2018

Merrill Lynch Bullish on Deep Value Pharmaceuticals: 5 Stocks to Buy for 2018

ImmunoGen Riding High on Jazz Pharma Deal

ImmunoGen and Jazz Enter Into Global Collaboration

Top Analyst Upgrades and Downgrades: Applied Materials, Cerner, Cisco, J&J, Level 3, Salesforce and Many More

Top Analyst Upgrades and Downgrades: AMD, Panera, SeaWorld, T-Mobile, Walgreens, 8Point3 and Many More

Wednesday’s Top Biopharma Winners

Why This Analyst Sees Huge Upside for Valeant and 2 More Specialty Pharmas

Jazz Pharma Pays $1.5 Billion for Celator

Jim Cramer to Brinker’s CEO: How Do You Make More Money When Every Cost Is Going the Wrong Way?

Retirees Are Realizing a $1.5 Million Nest Egg at 60 Only Means $31,000 in Real Annual Spending

Turning $250K Into $1M in 5 Years: Why This Real Estate Promise Is a Red Flag

Featured Reads

Retirees Are Realizing a $1.5 Million Nest Egg at 60 Only Means $31,000 in Real Annual Spending

71% of Americans With Financial Advisors Feel Secure. Only 10% Without One Do